Wednesday 17 January 2018

Bard Shannon turnover up as profits fall

Gordon Deegan

PRE-TAX profits at the Irish subsidiary of US-owned health care manufacturer, CR Bard fell in 2009 by 32pc to $100.2m (€75m) in spite of an increase in revenues.

Recent filings show the Dublin-based Bard Shannon Ltd increased its revenues by 5pc from $694.2m to $729.6m to the end of December 2009.

In spite of this, pre-tax profits dropped by $47.2m.

The directors' report for the holding company states that they expect the increase in turnover to continue.

However, the increase in revenues "has been offset to a large extent by a corresponding increase in the costs of materials, labour and overheads".

CR Bard, Inc. is a leading multinational developer, manufacturer, and seller of innovative life-enhancing medical technologies in the fields of vascular, urology, oncology, and surgical specialty products.

The $729m in turnover represents 29pc of the corporation's global sales in 2009 of $2.5bn. The company employs 11,000 worldwide.

During 2009, the Irish-based holding company made a payment of $4.4m to its US parent. The dividend was made "in connection with the parent company's plans to repatriate foreign earnings which were previously taxed for US tax purposes".

Irish Independent

Promoted Links

Business Newsletter

Read the leading stories from the world of Business.

Promoted Links

Also in Business